September 29 is noticed as World Coronary heart Day. In India, a coronary heart assault happens each 33 seconds, claiming over two million lives yearly. But, as much as 80% of those deaths are preventable. Virtually tripling in prevalence for the reason that Nineties, cardiovascular illnesses (CVDs) have silently grow to be India’s main killer, claiming one in each 4 lives. The typical age for a primary coronary heart assault in India is simply 50, a decade sooner than in western international locations. Shockingly, CVDs additionally account for 45% of deaths within the 40–69-year age group. This silent epidemic pushes households into monetary misery and diminishes survivors’ high quality of life.
The influence of early-onset CVD extends past well being, inflicting an estimated annual productiveness lack of ₹11.8 lakh crore. Stopping CVDs isn’t just a well being crucial however an financial necessity.
Nonetheless, present prevention methods face important challenges. Conventional well being care paints all 1.4 billion Indians with the identical broad brush, resulting in imprecise threat assessments and affected person non-compliance. Additionally, the frequent chorus of “What hurt can one samosa do?” echoes the feelings of many. This emotion positive factors credence as thousands and thousands with seemingly unhealthy habits reside lengthy lives, whereas some seemingly wholesome people succumb to sudden coronary heart assaults. The answer lies not solely in common and earlier check-ups but additionally in leveraging predictive precision medication and Synthetic Intelligence (AI).
Commonplace CVD prevention methods fail to handle the nation’s genetic variety and cultural nuances. Danger prediction fashions, largely primarily based on western populations, inadequately seize India’s distinctive threat profile. Tobacco use, bodily inactivity, genetic predisposition, poor weight loss program, and air air pollution additional compound the issue.
Conventional cardiac threat evaluation instruments solely assist gauge a broad likelihood of growing coronary heart illness. They basically solely reply in case you are at excessive threat or low threat. Whereas this categorisation is vital, it doesn’t determine precise causal elements or account for short-term threat for scientific follow-up, resulting in a majority of sufferers getting over-treated or under-treated.
Affected person compliance can also be a significant problem, stemming from resistance to testing, over-reliance on unproven life-style modifications, and the tendency to “keep on” till signs grow to be insufferable. Cultural beliefs additional complicate issues. The notion of conventional Indian diets as inherently wholesome overlooks their excessive carbohydrate content material, whereas the normalisation of situations like hypertension and diabetes as “frequent” or “familial” results in a harmful lack of urgency in looking for medical consideration. These challenges underscore the necessity for a extra nuanced, personalised strategy to CVD prevention.
Let’s think about the case of Amit, a 38-year-old IT skilled from New Delhi. Amit, health-conscious and proactive, undergoes his first complete well being check-up. His preliminary assessments are inside regular vary, albeit with barely elevated LDL ldl cholesterol. Following customary protocols, his physician advises statins, train and wholesome consuming with common follow-up.
Amit is immune to taking remedy at his age however understands his threat given his father’s angioplasty at 52. He opts for extra assessments utilizing predictive precision medication that mix genetic and scientific information with life-style elements utilizing AI to create a complete personalised threat profile.
The assessments provided a extra correct understanding of Amit’s CVD threat: Superior lipid panel confirms excessive lipoprotein(a), a threat issue usually missed in customary assessments; genetic testing detects variation within the APOC3 gene, related to regulation of triglyceride ranges; coronary artery calcium (CAC) scoring exhibits deposits within the arteries, a marker of plaque buildup; AI-driven threat evaluation predicts very excessive 10-year CVD threat — a lot greater than recommended by conventional calculators. These insights permit Amit’s physician to create a extra personalised 10-year CVD prevention plan; instantly beginning Amit on statins, extra aggressive life-style modification, common lipid profile and different related investigations.
This threat evaluation additionally made Amit extra attentive to well being recommendation. By 55, regardless of a household historical past of early coronary heart illness, Amit maintained good cardiovascular well being.
Whereas customary testing stays essential for baseline well being evaluation, precision medication affords deeper insights into particular person threat elements, permitting for extra correct threat stratification and tailor-made prevention methods. Mass implementation of predictive precision medication will not be instantly possible as a result of value and restricted availability. However incorporating superior genetic testing and biomarker evaluation into company well being check-ups affords a place to begin. This strategy not solely protects an important phase of our workforce but additionally gives a resource-effective mannequin that would unlock cost-effectiveness when carried out at scale.
This information might considerably advance how we strategy cardiovascular well being on the inhabitants stage. By analysing this complete dataset, researchers might determine novel biomarkers and threat elements distinctive to the Indian context. This data might be used to develop new prediction fashions, algorithms, or instruments extra precisely tailor-made for our inhabitants. Such instruments, when validated and carried out, might improve the effectiveness of present authorities programmes focused to handle the rising incidence of non-communicable illnesses. This might enhance threat stratification at major well being centres, doubtlessly resulting in extra focused interventions and environment friendly use of tertiary care assets for high-risk people.
As we advance, moral challenges round information privateness, knowledgeable consent, and genetic discrimination are more likely to emerge necessitating the formation of complete tips for the usage of genetic and biomarker information. Regardless of the potential challenges, the mixing of predictive precision medication into India’s CVD administration technique affords an unprecedented alternative to deal with this epidemic holistically.
Dr Naresh Trehan is chairman and managing director of Medanta.The views expressed are private
